Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Kleinman

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Current Opinion in Hematology|September 22, 2015
Pathogen inactivation: emerging indicationsSteven Kleinman
Transfusion|September 13, 2006
A perspective on transfusion-related acute lung injury two years after the Canadian Consensus ConferenceSteven Kleinman
Vox Sanguinis|March 6, 2003
Research, monitoring, and policy issues related to emerging pathogensSteven Kleinman
Transfusion|September 30, 2018
Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied interventionSteven Kleinman, Adonis Stassinopoulos
The Lancet. Haematology|May 14, 2019
Building consensus: steps toward standardised haemovigilance reportingNareg Roubinian, Steven Kleinman
Transfusion|July 15, 2015
Database research in transfusion medicine: The power of large numbersSteven Kleinman, Simone A Glynn
Transfusion|July 19, 2003
Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectivesF Blaine Hollinger, Steven Kleinman
Transfusion|October 17, 2012
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United StatesSteven Kleinman, William Reed, Adonis Stassinopoulos
Transfusion|May 12, 2010
A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United StatesSteven Kleinman, Brenda Grossman, Patricia Kopko
Viruses|October 27, 2022
Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection RiskNico Lelie, Michael Busch, Steven Kleinman
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Current Opinion in Hematology|September 22, 2015
Pathogen inactivation: emerging indicationsSteven Kleinman
Transfusion|September 13, 2006
A perspective on transfusion-related acute lung injury two years after the Canadian Consensus ConferenceSteven Kleinman
Vox Sanguinis|March 6, 2003
Research, monitoring, and policy issues related to emerging pathogensSteven Kleinman
Transfusion|September 30, 2018
Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied interventionSteven Kleinman, Adonis Stassinopoulos
The Lancet. Haematology|May 14, 2019
Building consensus: steps toward standardised haemovigilance reportingNareg Roubinian, Steven Kleinman
Transfusion|July 15, 2015
Database research in transfusion medicine: The power of large numbersSteven Kleinman, Simone A Glynn
Transfusion|July 19, 2003
Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectivesF Blaine Hollinger, Steven Kleinman
Transfusion|October 17, 2012
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United StatesSteven Kleinman, William Reed, Adonis Stassinopoulos
Transfusion|May 12, 2010
A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United StatesSteven Kleinman, Brenda Grossman, Patricia Kopko
Viruses|October 27, 2022
Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection RiskNico Lelie, Michael Busch, Steven Kleinman
Pageof 8